Scoping review of HbA1c device use in selected Asian countries: Implications for point-of-care testing in Nepal

Introduction Type 2 diabetes mellitus (T2DM) is rising globally, while access to HbA1c testing is limited in low-resource settings such as Nepal. This review aimed to facilitate the implementation of point-of-care (POC) HbA1c testing in Nepal by examining the use of HbA1c devices. The review focused on three objectives: (1) identifying HbA1c devices used in studies conducted in Nepal and determining which are POC devices, (2) assessing the use of POC HbA1c devices across selected Asian countries, and (3) evaluating how these devices are reported in the literature. Methods Following PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews) and the Joanna Briggs Institute (JBI) guidelines, major bibliographic databases (PubMed, EBSCOhost, and Web of Science) were searched for studies published in English up to January 20, 2025. This scoping review did not include formal risk-of-bias assessments, diagnostic accuracy meta-analyses, or comparative device appraisals. Results For the first objective, 26 studies from Nepal were identified; 14 used POC devices, including the DCA Vantage, while 12 used laboratory-based instruments. For the second objective, 25 studies from 11 countries reported widespread use of POC devices, including A1C EZ 2.0 and HbA1c 501. For the third objective, 67 studies were analyzed to evaluate the use of POC devices identified in selected Asian studies. The most frequently studied devices included DCA Vantage, A1CNow+, Afinion AS100, and in2it. Conclusions While laboratory testing remains dominant among the included Nepalese studies, access is limited in rural areas. Evidence suggests the potential applicability of POC devices in community environments, offering the possibility to improve diabetes management in resource-limited settings. Particularly in low- and middle-income countries, their successful implementation requires ongoing performance monitoring, adequate training, and standardized quality assurance. Further field-based research and local validation studies are needed to evaluate device performance and implementation readiness across diverse real-world settings.

Authors

Institutions

Publication Details

Journal
PLoS ONE
Published
2026-11-19
DOI
https://doi.org/10.1371/journal.pone.0340245
Primary Topic
Diabetes Management and Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Scoping review of HbA1c device use in selected Asian countries: Implications for point-of-care testing in Nepal

Ishtiaq Ahmad, Lal Bahadur Rawal, Deepa Makaju, Haruka Sakamoto et al.
PLoS ONE
Diabetes Management and Research
article

Scoping review of HbA1c device use in selected Asian countries: Implications for point-of-care testing in Nepal

Ishtiaq Ahmad, Lal Bahadur Rawal, Deepa Makaju, Haruka Sakamoto, Abha Shrestha, Tomohiko Sugishita, Rabina Shrestha, Hanako Iwashita, Gaku Masuda, Biraj Man Karmacharya, Pratiksha Gyawali
article en

Abstract

Introduction Type 2 diabetes mellitus (T2DM) is rising globally, while access to HbA1c testing is limited in low-resource settings such as Nepal. This review aimed to facilitate the implementation of point-of-care (POC) HbA1c testing in Nepal by examining the use of HbA1c devices. The review focused on three objectives: (1) identifying HbA1c devices used in studies conducted in Nepal and determining which are POC devices, (2) assessing the use of POC HbA1c devices across selected Asian countries, and (3) evaluating how these devices are reported in the literature. Methods Following PRISMA-ScR (Preferred Reporting Items for Systematic Reviews and Meta-Analyses for Scoping Reviews) and the Joanna Briggs Institute (JBI) guidelines, major bibliographic databases (PubMed, EBSCOhost, and Web of Science) were searched for studies published in English up to January 20, 2025. This scoping review did not include formal risk-of-bias assessments, diagnostic accuracy meta-analyses, or comparative device appraisals. Results For the first objective, 26 studies from Nepal were identified; 14 used POC devices, including the DCA Vantage, while 12 used laboratory-based instruments. For the second objective, 25 studies from 11 countries reported widespread use of POC devices, including A1C EZ 2.0 and HbA1c 501. For the third objective, 67 studies were analyzed to evaluate the use of POC devices identified in selected Asian studies. The most frequently studied devices included DCA Vantage, A1CNow+, Afinion AS100, and in2it. Conclusions While laboratory testing remains dominant among the included Nepalese studies, access is limited in rural areas. Evidence suggests the potential applicability of POC devices in community environments, offering the possibility to improve diabetes management in resource-limited settings. Particularly in low- and middle-income countries, their successful implementation requires ongoing performance monitoring, adequate training, and standardized quality assurance. Further field-based research and local validation studies are needed to evaluate device performance and implementation readiness across diverse real-world settings.

PLoS ONEVol. 21(11)
Dhulikhel Hospital (NP), Juntendo University (JP), St. Luke's International University (JP), Tokyo Women's Medical University (JP), Nagasaki University (JP), Kathmandu University (NP), Western Sydney University (AU), Central Queensland University (AU)
Diabetes Management and Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon